Amgen Inc. v. F. Hoffmann-LaRoche LTD et al
Filing 926
DECLARATION Of William G. Gaede in Support of Amgen Inc.'s Motion In Limine No. 22 to Preclude Roche from Introducing, Including in its Invalidity Opening, Testimony, Evidence or Argument on Pegylation During the Validity Phase of the Trial and to Exclude Any Proffered Testimony by Dr. Robert Langer During the Trial by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3-1#4 Exhibit 3-2#5 Exhibit 4)(Gottfried, Michael)
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.